Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

DataMeds AI, Inc.

CIK 2030763 MEDS·Wholesale Trade · All EDGAR filings ↗

Progression

  1. Going concern 10-K
  2. Late filing NT 10-Q +56d
Refine
Form
An amendment is grouped with the report it amends; every 12b-25 notice is one group

Late filing Filing comparison

DataMeds AI, Inc. told the SEC it could not file its quarterly report on time

Does not expect a significant change in results. Filed on the statutory due date.

(the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 (the “Form 10-Q”), which is due on August 14, 2026. The Company has determined that the Form 10-Q cannot be filed within the prescribed time period without unreasonable effort or expense. The Company requires additional time to complete the preparation and review of its financial statements and related disclosures to be included in the Form 10-Q.
Evidence
Anticipates significant change
No
Days past due date
0
Other periodic reports filed
Yes
Routine
Yes
Severity
normal
Source
Form 12b-25 (notification of late filing)
Stated reason
(the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 (the “Form 10-Q”), which is due on August 14, 2026. The Company has determined that the Form 10-Q cannot be filed within the prescribed time period without unreasonable effort or expense. The Company requires additional time to complete the preparation and review of its financial statements and related disclosures to be included in the Form 10-Q.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.

Source filing ↗

Late filing Filing comparison

Wellgistics Health, Inc. told the SEC it could not file its quarterly report on time

Does not expect a significant change in results. Filed on the statutory due date.

(the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (the “Form 10-Q”), which is due on May 15, 2026. The Company has determined that the Form 10-Q cannot be filed within the prescribed time period without unreasonable effort or expense. The Company requires additional time to complete the preparation and review of its financial statements and related disclosures to be included in the Form 10-Q.
Evidence
Anticipates significant change
No
Days past due date
0
Routine
Yes
Severity
normal
Source
Form 12b-25 (notification of late filing)
Stated reason
(the “Company”) is filing this Notification of Late Filing on Form 12b-25 with respect to its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 (the “Form 10-Q”), which is due on May 15, 2026. The Company has determined that the Form 10-Q cannot be filed within the prescribed time period without unreasonable effort or expense. The Company requires additional time to complete the preparation and review of its financial statements and related disclosures to be included in the Form 10-Q.
Why
The company told the SEC it could not file a periodic report on time, using Form 12b-25.
Formerly
Wellgistics Health, Inc.

Source filing ↗

Going concern Filing comparison

Wellgistics Health, Inc. said management's plans alleviate substantial doubt about going concern

Substantial doubt about ability to continue as a going concern → Substantial doubt raised, alleviated by management's plans

LIQUIDITY AND GOING CONCERN For the years ended December 31, 2025 and 2024, the Company has a net loss of $101,274,530 and $6,856,226, respectively, and had an accumulated deficit of $111,031,690 as of December 31, 2025. For the year ended December 31, 2025, the Company has net cash used in operating activities of $10,855,029. These factors raise substantial doubt about the Company’s ability to continue as a going concern within twelve months from the date these consolidated financial statements are issued. F- 16 Management Plan Subsequent to December 31, 2025, the Company completed two…
Evidence
Blank check
No
Comparable
Yes
Current state
doubt_alleviated
Current state label
Substantial doubt raised, alleviated by management's plans
Direction
eased
Located in
going-concern note
Prior filed
2025-03-25
Prior form
10-K
Prior state
substantial_doubt
Prior state label
Substantial doubt about ability to continue as a going concern
Source
ASC 205-40 going-concern note comparison
Why
Disclosure about the company's ability to continue as a going concern changed compared with its previous report.
Formerly
Wellgistics Health, Inc.

Source filing ↗ Prior filing ↗

Revenue recognition change beta Filing comparison

Wellgistics Health, Inc. changed its revenue recognition disclosure

The Company recognizes revenue from contracts with customers under ASC 606, Revenue from Contracts with Customers (“ASC 606”).
Evidence
New language
The Company recognizes revenue from contracts with customers under ASC 606, Revenue from Contracts with Customers (“ASC 606”)., Cost of net revenues includes provisions for inventory obsolescence and charges related to vendor shipping advances for which no supplies have been made and are no longer considered recoverable.
Prior filed
2025-03-25
Prior form
10-K
Similarity
0.207
Source
revenue recognition note comparison
Threshold
0.6
Why
The revenue recognition policy disclosure changed materially from the previous comparable filing.
Formerly
Wellgistics Health, Inc.

Language present now, absent from the prior filing:

  • The Company recognizes revenue from contracts with customers under ASC 606, Revenue from Contracts with Customers (“ASC 606”).
  • Cost of net revenues includes provisions for inventory obsolescence and charges related to vendor shipping advances for which no supplies have been made and are no longer considered recoverable.

Source filing ↗ Prior filing ↗